MA and Part D Final Rule
The CMS 2027 MA and Part D Final Rule
Is Not What It Looks Like
Most organizations will read the CMS CY 2027 Medicare Advantage and Part D Final Rule and walk away with a checklist. Quality measures updated. Star Ratings adjusted. Supplemental benefits clarified. Part D changes continue to unfold.
On the surface, it feels incremental. Manageable. Familiar.
It is not.
The CMS 2027 MA and Part D Final Rule is another step in a much broader recalibration of how performance is defined, measured, and ultimately paid for. This is less about any one provision and more about direction. The organizations that treat this as a routine regulatory update will keep up. The ones that understand what is being built underneath it will move ahead.
Quality Measures Are Becoming More Meaningful
CMS is removing 11 administrative process measures while introducing a new Part C Depression Screen and Follow-Up measure. That pairing is not accidental.
For years, there has been tension between measuring activity and measuring impact. Administrative measures often captured whether something was done, not whether it mattered. Their removal signals a continued move away from box-checking and toward measures that more directly reflect clinical outcomes and patient experience.
At the same time, the addition of a behavioral health measure is a quiet but important escalation. Depression screening and follow-up are not new concepts, but embedding them into STAR performance elevates behavioral health into the core of quality strategy rather than leaving it adjacent to it.
What this suggests, more broadly, is a continued shift in what CMS values. Quality is no longer being framed as a collection of tasks. It is being reframed as a reflection of integrated care. Behavioral health, in particular, is no longer optional to get right.
Star Ratings Stability Does Not Mean Stability
CMS chose not to implement the Excellent Health Outcomes for All reward and instead maintained the historical reward factor across all enrollees. It is easy to interpret this as a pause on health equity initiatives.
It is more accurate to see it as pacing.
CMS has been consistent in signaling that health equity will remain a central theme in program design. The absence of a new reward structure in 2027 does not remove that pressure. It simply delays how it shows up in the financial model.
For organizations, this creates an interesting dynamic. There is a temptation to align strategy only with what is immediately incentivized. But the more sophisticated players are doing something different. They are building equity-informed care models now, anticipating that measurement and reimbursement will eventually catch up.
That mindset shift matters because it moves organizations from reactive to prepared.
Supplemental Benefits Are Being Brought Into the Light
CMS is strengthening Special Supplemental Benefits for the Chronically Ill by clarifying eligibility requirements and requiring plans to publicly post their criteria. On paper, that sounds like a technical update. In practice, it changes how these benefits will be used and scrutinized.
Transparency has a way of forcing clarity. When eligibility criteria are visible, they must be defensible. When they are defensible, they tend to align more closely with clinical intent rather than marketing differentiation.
There are also a few important guardrails being reinforced here. CMS is explicitly clarifying that cannabis products are not allowable under SSBCI, removing a gray area that some plans were navigating. At the same time, the agency is tightening expectations around debit card use to ensure that supplemental benefits are used as designed.
Taken together, these changes point toward a more structured approach to benefit design. One that is less about creativity for its own sake and more about measurable impact.
Part D Changes Continue to Reshape the Economics
CMS is continuing to codify provisions from the Inflation Reduction Act, including eliminating the coverage gap phase and lowering the annual out-of-pocket threshold. These are not new concepts, but their continued implementation is materially changing how financial responsibility is distributed.
For organizations offering integrated MA and Part D products, this is where things become more complex. Pharmacy is no longer something that can be modeled in isolation. Changes to out-of-pocket thresholds influence member behavior, which in turn affects adherence, utilization, and ultimately total cost of care.
It is not just a benefit design issue. It is a financial modeling issue.
And it raises a set of questions that many organizations are still working through:
- How will lower out-of-pocket costs influence utilization patterns?
- Where might adherence improvements shift downstream medical costs?
- How should plan liability be recalibrated over the next several years?
The answers are not static. They require ongoing adjustment as the policy continues to take shape.
Regulatory Relief Is Not What It Seems
CMS is also removing several requirements that have long been viewed as burdensome, including mid-year notices about unused supplemental benefits and certain quality improvement program requirements related to health disparities.
It would be easy to interpret this as CMS stepping back. That is not what is happening.
What CMS is doing instead is refining where it applies pressure. The agency is moving away from requirements that generate activity without clear value and focusing more on areas that produce measurable outcomes.
Oversight is not decreasing. It is becoming more targeted.
For organizations, this means that compliance may feel simpler in some areas, but expectations are actually becoming more precise. The margin for loosely defined processes continues to narrow.
What This Is Really Pointing Toward
If you step back from the individual provisions, a consistent pattern starts to emerge.
- Quality is being tied more closely to real clinical impact
- Behavioral health is being embedded into core performance expectations
- Supplemental benefits are being pushed toward transparency and accountability
- Financial responsibility is continuing to shift across the Part D structure
- Regulatory expectations are becoming more focused, not less
None of this is particularly loud on its own. But together, it represents a steady alignment between policy intent and operational reality. That alignment is where the real change is happening.
The Question for Leadership Teams
At this point, most organizations understand what changed. The more important question is whether they understand what those changes are building toward. That requires a different kind of conversation. One that moves beyond implementation and into strategy.
It is the difference between asking what needs to be done this year and asking what needs to be true over the next three.
For many leadership teams, that conversation is starting to center around a few core themes:
- How do we integrate behavioral health in a way that impacts both quality and cost?
- Where are supplemental benefits actually influencing outcomes versus perception?
- How do Part D changes reshape our total cost of care assumptions?
- What does a more transparent, more defensible operating model actually look like?
These are not compliance questions. They are positioning questions.
Looking Ahead
CMS also released proposed rules for inpatient hospitals, skilled nursing facilities, hospice, and inpatient rehabilitation facilities. While separate from Medicare Advantage and Part D, they reinforce the same underlying themes of accountability, alignment, and financial recalibration.
There is a consistency to where all of this is heading. And that consistency is the signal. By the time these policies are fully operational, the organizations that recognized that signal early will already be positioned for it.
Additional Resources
For those who want to go deeper into the specifics, CMS has published several supporting materials:
- https://www.cms.gov/newsroom/fact-sheets/contract-year-2027-medicare-advantage-and-part-d-final-rule
- https://www.cms.gov/newsroom/press-releases/cms-finalizes-payments-and-policies-medicare-advantage-and-part-d-programs-2027
- https://www.cms.gov/medicare/health-plans/medicareadvtgspecratestats
NAACOS will also be providing additional education and insights:
CMS has also released related proposed rules across care settings:
- https://www.cms.gov/medicare/payment/prospective-payment-systems
- https://www.cms.gov/medicare/payment/prospective-payment-systems/skilled-nursing-facility-snf
- https://www.cms.gov/medicare/payment/prospective-payment-systems/hospice
- https://www.cms.gov/medicare/payment/prospective-payment-systems/inpatient-rehabilitation-facility
Explore the Health Access Card and see what true connectivity looks like
👉 www.healthaccesscard.com
